Request for Proposals: Targeted Biomedical Research
Exploring the mechanisms for HIV persistence and the potential for HIV eradication
amfAR, The Foundation for AIDS Research, is pleased to announce the availability of targeted support for biomedical research projects relevant to exploring the mechanisms for HIV persistence and the potential for HIV eradication.
Total Cost Maximum: $180,000
Performance Period: February 1, 2015 – January 31, 2017
BACKGROUND AND AREAS OF INTEREST
This RFP solicits proposals relevant to exploring the mechanisms for HIV persistence and the potential for HIV eradication. Highly active antiretroviral therapy (HAART) has significantly impacted the health of individuals infected with HIV-1. However, if therapy is interrupted, there is a rapid resumption of viral replication. Understanding the mechanisms by which the virus is able to persist in the face of therapy is necessary in order to identify strategies that may interrupt viral persistence and ultimately lead to viral eradication. amfAR wishes to support basic, pre-clinical, clinical, and especially translational research exploring the mechanisms whereby HIV infection persists; the chronic nature of viral reservoirs and latency; and barriers to the eradication of HIV, with the potential goal of ultimately curing HIV infection.
Specific areas of interest fall within the following four categories:
- Determine the location of persistent reservoirs of HIV in tissues, cell subsets or within cells
- Determine the cellular and viral mechanisms and kinetics that establish and/or maintain HIV persistence
- Develop, compare, or validate assays to measure persistent infection
- Develop and test strategies to safely eliminate or control viral reservoirs (in the absence of ART)
Collaborations within or between institutions are encouraged.
Applicants are encouraged to submit proposals using appropriate in vitro or ex-vivo techniques. Attempts to validate existing in vitro or ex vivo models, and to develop new models, including animal systems, are also encouraged.
Applicants proposing studies involving nonhuman primates or other appropriate animal models are encouraged to apply.
amfAR is particularly interested in supporting clinical projects whose budget fits within the parameters of this RFP. Alternatively, applicants who wish to use amfAR funding to conduct a discrete clinical research project, for example as a definable, distinct part of an ongoing clinical trial, should clearly describe how amfAR funding can support the entire discrete project for which funding is sought. Proposals for which amfAR funding will represent a small fraction of pooled resources (i.e., to "top up" total funding of a clinical research project) will not be considered.
Applicants are especially encouraged to design research studies in which the findings from basic science can be quickly and efficiently applied to medical practice. Such applications are likely to include multi-disciplinary collaboration and a description of the ways in which basic science findings generated with this funding can or will be tested (using this funding) in an appropriate non-human primate model or in patients.
- The total cost maximum is $180,000
- There is no direct cost maximum, however, indirect costs may not be greater than 20% of direct costs
- This RFP solicits projects to be completed in the 24 month period starting February 1, 2015
- It is not required that principal investigators hold a faculty-level position
Please note that all applications will be considered together (i.e., proposals from non-faculty-level researchers will be in competition with proposals from faculty-level investigators).
- Must hold a doctoral level degree
- Must be affiliated with the applicant institution
- If the proposal is a collaboration including subcomponent projects, the principal investigator will be expected to lead one of the component projects, coordinate the development, implementation and analysis of the projects as a whole, and be responsible for overall financial management and the preparation and submission of required reports.
Applications are accepted from nonprofit research institutions worldwide; applications are not accepted from individuals or for-profit entities. However, although the Principal Investigator must be affiliated with the applicant institution, research teams may include members from, and budgets may include subcontracts with or subawards to for-profit entities.
SUBMISSION REQUIREMENTS AND DEADLINES
Submission of targeted grant letters of inquiry and applications is now an online process.
Interested applicants must take the following steps to request web portal log-in credentials and Letter of Intent (LOI) forms and instructions:
CLICK HERE to download the request form .
Complete the form and email it to email@example.com.
Log-in credentials are not interchangeable. A separate form request must be sent for each potential principal investigator .
Please be sure to request the forms with adequate time to complete them. Deadline extensions will not be provided.
It is strongly suggested that you request log-in credentials and LOI materials no later than 12:00 PM EDT on October 10, 2014. Please note that amfAR’s offices will be closed in observance of Columbus Day on October 13, 2014.
- Online LOI submission: October 15, 2014, 5:00 PM EDT
- Signed hard copy of LOI signature page: October 22, 2014, 5:00 PM EDT
Submission of an LOI is not a guarantee of eligibility to submit a full application. The pre-application process is highly competitive. Only a limited number of investigators submitting an LOI will be invited to submit a full application.
OTHER IMPORTANT DATES
November 14, 2014 (tentative)
E-mailed application submissions due:
December 16, 2014 (tentative)
Funding decisions announced:
Mid-February, 2015 (tentative)
Click here to sign up for e-mailed Grant Opportunity announcements.